iShares US Pharmaceuticals ETF
120 hedge funds and large institutions have $404M invested in iShares US Pharmaceuticals ETF in 2015 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 35 reducing their positions, and 9 closing their positions.
111% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 9
29% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 35
8% more funds holding
Funds holding: 111 → 120 (+9)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
8% less capital invested
Capital invested by funds: $441M → $404M (-$36.7M)
11.89% less ownership
Funds ownership: 116.14% → 104.24% (-12%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$5.97M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$4.32M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.74M |
| 4 |
UFF
USA Financial Formulas
Ada,
Michigan
|
+$3.73M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$54.5M |
| 2 |
BHB
Bank Hapoalim BM
Tel Aviv,
Israel
|
-$9.59M |
| 3 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$8.85M |
| 4 |
AWA
ARS Wealth Advisors
St. Petersburg,
Florida
|
-$3.81M |
| 5 |
SG Americas Securities
New York
|
-$3.11M |
IHE Hedge Fund Activity: Q2 2015 in Review
120 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q2 2015, worth a combined $404M — down 8.3% from $441M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new IHE positions and 9 closed out — a net gain of 10 holders — while 45 added to existing stakes and 35 trimmed.
The largest buyer was Raymond James & Associates, adding an estimated $5.97M. The largest seller was Bank of Montreal, cutting an estimated $54.5M.
- 120 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q2 2015, up from 111 in Q1 2015.
- Funds reported $404M of iShares US Pharmaceuticals ETF stock for Q2 2015, down 8.3% quarter-over-quarter.
- 19 funds opened new iShares US Pharmaceuticals ETF positions in Q2 2015 and 9 closed out, a net change of +10 holders.
- The largest iShares US Pharmaceuticals ETF buyer in Q2 2015 was Raymond James & Associates, an estimated $5.97M added.
- The largest iShares US Pharmaceuticals ETF seller in Q2 2015 was Bank of Montreal, an estimated $54.5M sold.
Based on aggregated 13F filings for Q2 2015.